Fundz

Who to call at Gannet BioChem, and when

Fundz watches for the moments Gannet BioChem starts buying, and tells you who to reach.

  • An alert the day Gannet BioChem raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Gannet BioChem, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Gannet BioChem. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Gannet BioChem Partners with Serina Therapeutics to Advance SER-252 for Parkinson's Disease.

Jun 30, 2026

Contract Type

partnership

HuntsvilleManufacturingBiotechnology

Description

Gannet BioChem has entered a development partnership with Serina Therapeutics to support the SER-252 program, an investigational therapy for advanced Parkinson's disease. The collaboration combines Gannet's manufacturing expertise with Serina's proprietary POZ Platform™ technology, aiming to expedite the clinical development of SER-252 following FDA clearance of its IND application.

Quick answer

Gannet BioChem Partners with Serina Therapeutics to Advance SER-252 for Parkinson's Disease. (June 30, 2026). Gannet BioChem is based in Huntsville, Alabama, United States.

What agreement did Gannet BioChem announce on June 30, 2026?
Gannet BioChem has entered a development partnership with Serina Therapeutics to support the SER-252 program, an investigational therapy for advanced Parkinson's disease. The collaboration combines Gannet's manufacturing expertise with Serina's proprietary POZ Platform™ technology, aiming to expedite the clinical development of SER-252 following FDA clearance of its IND application.
What does Gannet BioChem do?
Gannet BioChem is a leading specialty CDMO with over 30 years of expertise in developing, scaling, and manufacturing polyethylene glycol (PEG) reagents—essential components in advanced biopharmaceutical and therapeutic...
Where is Gannet BioChem based?
Gannet BioChem is based in Huntsville, Alabama, United States.

Source: Fundz verified event record.

Company Information

Company

Gannet BioChem

Location

Huntsville, Alabama, United States

About

Gannet BioChem is a leading specialty CDMO with over 30 years of expertise in developing, scaling, and manufacturing polyethylene glycol (PEG) reagents—essential components in advanced biopharmaceutical and therapeutic products. Operating from a 124,000 sq. ft. FDA-inspected facility in Huntsville, Alabama, the company provides end-to-end GMP production to support both clinical and commercial therapeutics. With a seasoned team, flexible production capabilities, and an unwavering commitment to quality, Gannet BioChem delivers reliable, innovative solutions for the global biopharmaceutical industry.

Related People

Nicholas
Likely contact at this company
••••••••@••••••••

See Nicholas's verified email →

Bob
Likely contact at this company
••••••••@••••••••

See Bob's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Gannet BioChem's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Gannet BioChem signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.